Simultaneous quantification of oestrogens and androgens in the serum of patients with benign prostatic hyperplasia by liquid chromatography-Tandem mass spectrometry

被引:7
作者
Yang, Tingting [1 ]
Huang, Yuhan [2 ]
Zhou, Yi [1 ]
Chen, Shangxiu [1 ]
Wang, Haiyan [1 ]
Hu, Yinlu [1 ]
Liu, Junjie [3 ]
Jiang, Zhenzhou [4 ]
Lu, Qian [1 ]
Yin, Xiaoxing [1 ]
机构
[1] Xuzhou Med Univ, Jiangsu Key Lab New Drug Res & Clin Pharm, Xuzhou, Jiangsu, Peoples R China
[2] Xuzhou Med Univ, Affiliated Hosp, Dept Pharm, Xuzhou, Jiangsu, Peoples R China
[3] Xuzhou Med Univ, Affiliated Hosp, Dept Urol, Xuzhou, Jiangsu, Peoples R China
[4] China Pharmaceut Univ, Jiangsu Key Lab Drug Screening, Nanjing, Peoples R China
基金
中国国家自然科学基金;
关键词
androgens; benign prostate hyperplasia; clinical samples; hormones homeostasis; LC-MS; MS; oestrogens; DIABETIC-NEPHROPATHY; TESTOSTERONE; EXTRACT; ESTRADIOL; BLOOD; HORMONES; PATHWAY; IMPACT; RATIO;
D O I
10.1111/and.13611
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
Benign prostate hyperplasia (BPH) is a common disease in elderly men. It has been found that the occurrence of BPH was closely related to dysregulated steroid hormones. Here, a rapid, sensitive, accurate and specific method for the quantitative profiling of five androgens in man serum was developed and validated by the use of liquid chromatography-tandem mass spectrometry (LC-MS/MS). Using this method, dehydroepiandrosterone (DHEA), androstenedione (A4), testosterone (T), androsterone (A), dihydrotestosterone (DHT), oestrone (E1) and oestradiol (E2) were quantified in serum from man with and without BPH. BPH patients were characterised by the decreases in DHEA, A4 and T as well as increases in DHT, E2 and E1 in serum. Meanwhile, DHEA and DHT in serum were screened as sensitive biomarkers of BPH patients. This study will provide a new perspective of dysregulated steroid hormones for the diagnosis and prevention of BPH.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Effect of Serenoa repens extract (Permixon(R)) on estradiol/testosterone-induced experimental prostate enlargement in the rat
    PaubertBraquet, M
    Richardson, FO
    ServentSaez, N
    Gordon, WC
    Monge, MC
    Bazan, NG
    Authie, D
    Braquet, P
    [J]. PHARMACOLOGICAL RESEARCH, 1996, 34 (3-4) : 171 - 179
  • [32] Action Mechanism of Ginkgo biloba Leaf Extract Intervened by Exercise Therapy in Treatment of Benign Prostate Hyperplasia
    Peng, Chiung-Chi
    Liu, Jia-Hong
    Chang, Chi-Huang
    Chung, Jin-Yuan
    Chen, Kuan-Chou
    Chou, Kuang-Yu
    Peng, Robert Y.
    [J]. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2013, 2013
  • [33] Ulmus macrocarpa Hance improves benign prostatic hyperplasia by regulating prostatic cell apoptosis
    Rho, Jinhyung
    Seo, Chang-Seob
    Park, Hee-Seon
    Wijerathne, Charith U. B.
    Jeong, Hye-Yun
    Moon, Og-Sung
    Seo, Young-Won
    Son, Hwa-Young
    Won, Young-Suk
    Kwun, Hyo-Jung
    [J]. JOURNAL OF ETHNOPHARMACOLOGY, 2019, 233 : 115 - 122
  • [34] Metabolic syndrome and benign prostatic hyperplasia: association or coincidence?
    Ryl, Aleksandra
    Rotter, Iwona
    Miazgowski, Tomasz
    Slojewski, Marcin
    Dolegowska, Barbara
    Lubkowska, Anna
    Laszczynska, Maria
    [J]. DIABETOLOGY & METABOLIC SYNDROME, 2015, 7
  • [35] Sensitive simultaneous quantitation of testosterone and estradiol in serum by LC-MS/MS without derivatization and comparison with the CDC HoSt program
    Schofield, Ryan C.
    Mendu, Damodara R.
    Ramanathan, Lakshmi V.
    Pessin, Melissa S.
    Carlow, Dean C.
    [J]. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2017, 1048 : 70 - 76
  • [36] Impact of pre-treatment prostate tissue androgen content on the prediction of castration-resistant prostate cancer development in patients treated with primary androgen deprivation therapy
    Shibata, Y.
    Suzuki, K.
    Arai, S.
    Miyoshi, Y.
    Umemoto, S.
    Masumori, N.
    Kamiya, N.
    Ichikawa, T.
    Kitagawa, Y.
    Mizokami, A.
    Sugimura, Y.
    Nonomura, N.
    Sakai, H.
    Honma, S.
    Kubota, Y.
    [J]. ANDROLOGY, 2013, 1 (03) : 505 - 511
  • [37] Androgens, lipogenesis and prostate cancer
    Swinnen, JV
    Heemers, H
    de Sande, TV
    De Schrijver, E
    Brusselmans, K
    Heyns, W
    Verhoeven, G
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2004, 92 (04) : 273 - 279
  • [38] Evaluation of the chemiluminescent enzyme immunoassay system for the measurement of testosterone in the serum and whole blood of stallions
    Toishi, Yuko
    Tsunoda, Nobuo
    Nagata, Shun-ichi
    Kirisawa, Rikio
    Nagaoka, Kentaro
    Watanabe, Gen
    Yanagawa, Yojiro
    Katagiri, Seiji
    Taya, Kazuyoshi
    [J]. JOURNAL OF REPRODUCTION AND DEVELOPMENT, 2018, 64 (01) : 41 - 47
  • [39] Serum Sex Steroids as Prognostic Biomarkers in Patients Receiving AndrogenDeprivation Therapy for Recurrent Prostate Cancer: A Post Hoc Analysis of the PR.7 Trial
    Toren, Paul
    Hoffman, Azik
    Ding, Keyue
    Joncas, France-Helene
    Turcotte, Veronique
    Caron, Patrick
    Pouliot, Frederic
    Fradet, Yves
    Levesque, Eric
    Guillemette, Chantal
    Klotz, Laurence
    [J]. CLINICAL CANCER RESEARCH, 2018, 24 (21) : 5305 - 5312
  • [40] Power Doppler ultrasonography of the feeding arteries of the prostate gland -: A novel approach to the diagnosis of prostate cancer?
    Turgut, Ahmet Tuncay
    Oelcuecueoglu, Esin
    Kosar, Pinar
    Geyik, Pinar Oezdemir
    Kosar, Ugur
    Dogra, Vikram
    [J]. JOURNAL OF ULTRASOUND IN MEDICINE, 2007, 26 (07) : 875 - 883